Step-down from high dose fixed combination therapy in asthma patients: a randomized controlled trial

Respiratory Research

Volumn 13, Issue , 2012, Pages

  Papi, Alberto ^a   Nicolini, Gabriele ^b   Crimi, Nunzio ^c   Fabbri, Leonardo ^d   Olivieri, Dario ^e   Rossi, Andrea ^f   Paggiaro, Pierluigi ^g  

^a UNIVERSITY OF FERRARA   (Italy)

^b Medical Affairs Department   (Italy)

^c UNIVERSITY OF CATANIA   (Italy)

^d UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^e UNIVERSITY OF PARMA   (Italy)

^f UNIVERSITY HOSPITAL OF VERONA   (Italy)

^g UNIVERSITY OF PISA   (Italy)

Author keywords

Beclomethasone; Extrafine; Fluticasone; Formoterol; Salmeterol

Indexed keywords

BECLOMETASONE DIPROPIONATE PLUS FORMOTEROL FUMARATE; FLUTICASONE PROPIONATE PLUS SALMETEROL XINAFOATE; ANDROSTANE DERIVATIVE; BECLOMETASONE; BRONCHODILATING AGENT; DRUG DERIVATIVE; FLUTICASONE, SALMETEROL DRUG COMBINATION; SALBUTAMOL;

ADULT; ARTICLE; ASTHMA; CONTROLLED STUDY; DISEASE EXACERBATION; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PATIENT COMPLIANCE; PEAK EXPIRATORY FLOW; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; TREATMENT OUTCOME; ADOLESCENT; AGED; CONTROLLED CLINICAL TRIAL; DRUG ADMINISTRATION; DRUG COMBINATION; MIDDLE AGED; PATHOPHYSIOLOGY;

ADOLESCENT; ADULT; AGED; ALBUTEROL; ANDROSTADIENES; ASTHMA; BECLOMETHASONE; BRONCHODILATOR AGENTS; DRUG ADMINISTRATION SCHEDULE; DRUG COMBINATIONS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84862621035     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-13-54     Document Type: Article

References (23)

1. Global Initiative for Asthma (GINA) Global strategy for asthma management and prevention, revised 2009 www.ginasthma.org, Global Initiative for Asthma (GINA).
2. Gibson PG, Powell H, Ducharme FM. Long-acting beta2-agonists as an inhaled corticosteroid-sparing agent for chronic asthma in adults and children. Cochrane Database Syst Rev 2005, (4):CD005076.
3. O'Byrne PM, Naya IP, Kallen A, Postma DS, Barnes PJ. Increasing doses of inhaled corticosteroids compared to adding long-acting inhaled beta2-agonists in achieving asthma control. Chest 2008, 134:1192-1199. 10.1378/chest.08-1018, 18689590.
4. Bateman ED, Boushey HA, Bousquet J, Busse WW, Clark TJ, Pauwels RA, Pedersen SE. GOAL Investigators Group. Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study. Am J Respir Crit Care Med 2004, 170:836-844. 10.1164/rccm.200401-033OC, 15256389.
5. Chung KF, Caramori G, Adcock IM. Inhaled corticosteroids as combination therapy with beta-adrenergic agonists in airways disease: present and future. Eur J Clin Pharmacol 2009, 65:853-871. 10.1007/s00228-009-0682-z, 19557399.
6. Woolcock A, Rubinfeld AR, Seale JP, Landau LL, Antic R, Mitchell C, Rea HH, Zimmerman P. Thoracic Society of Australia and New Zealand, Asthma management plan. Med J Aust 1989, 151:650-653.
7. Reddel HK, Gibson PG, Peters MJ, Wark PA, Sand IB, Hoyos CM, Jenkins CR. Down-titration from high-dose combination therapy in asthma: Removal of long-acting beta(2)-agonist. Respir Med 2010, 104:1110-1120. 10.1016/j.rmed.2010.04.003, 20430604.
8. Diette GB, Patino CM, Merriman B, Paulin L, Riekert K, Okelo S, Thompson K, Krishnan JA, Quartey R, Perez-Williams D, Rand C. Patient factors that physicians use to assign asthma treatment. Arch Intern Med 2007, 167:1360-1366. 10.1001/archinte.167.13.1360, 17620528.
9. Fowler SJ, Currie GP, Lipworth BJ. Step-down therapy with low-dose fluticasone salmeterol combination or medium dose hydrofluoroalkane 134a-beclomethasone alone. J Allergy Clin Immunol 2002, 109:929-935. 10.1067/mai.2002.123869, 12063520.
10. Godard P, Greillier P, Pigearias B, Nachbaur G, Desfourgeres JL, Attali V. Maintaining asthma control in persistent asthma: comparison of three strategies in a 6-month double-blind randomised study. Respir Med 2008, 102:1124-1131. 10.1016/j.rmed.2008.03.014, 18606533.
11. Bateman ED, Jacques L, Goldfrad C, Atienza T, Mihaescu T, Duggan M. Asthma control can be maintained when fluticasone propionate/salmeterol in a single inhaler is stepped down. J Allergy Clin Immunol 2006, 117:563-570. 10.1016/j.jaci.2005.11.036, 16522454.
12. Peters SP, Anthonisen N, Castro M, Holbrook JT, Irvin CG, Smith LJ, Wise RA, . American Lung Association Asthma Clinical Research Centers Randomized comparison of strategies for reducing treatment in mild persistent asthma. N Engl J Med 2007, 356(20):2027-2039. American Lung Association Asthma Clinical Research Centers.
13. Koenig SM, Ostrom N, Pearlman D, Waitkus-Edwards K, Yancey S, Prillaman BA, Dorinsky P. Deterioration in asthma control when subjects receiving fluticasone propionate/salmeterol 100/50 mcg Diskus are "stepped-down". J Asthma 2008, 45(8):681-687. 10.1080/02770900802168695, 18951261.
14. Papi A, Paggiaro PL, Nicolini G, Vignola AM, Fabbri LM. Inhaled Combination Asthma Treatment versus SYmbicort (ICAT SY) Study Group. Beclomethasone/formoterol versus budesonide/formoterol combination therapy in asthma. Eur Respir J 2007, 29:682-689. 10.1183/09031936.00095906, 17107988.
15. Papi A, Paggiaro P, Nicolini G, Vignola AM, Fabbri LM, . ICAT SE study group Beclomethasone/formoterol vs fluticasone/salmeterol inhaled combination in moderate to severe asthma. Allergy 2007, 62:1182-1188. 10.1111/j.1398-9995.2007.01493.x, 17845589, ICAT SE study group.
16. GOLD Report Executive Summary Global Strategy for Diagnosis, Management, and Prevention of COPD. December 2009. GOLD - Global Initiative for Chronic Obstructive Lung Disease home page http://www.goldcopd.org, GOLD Report Executive Summary.
17. Santanello NC, Zhang J, Seidenberg B, Reiss TF, Barber BL. What are minimal important changes for asthma measures in a clinical trial?. Eur Respir J 1999 Jul, 14(1):23-27.
18. Pauwels RA, Löfdahl CG, Postma DS, Tattersfield AE, O'Byrne P, Barnes PJ, Ullman A. Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group. N Engl J Med 1997, 337(20):1405-1411. 10.1056/NEJM199711133372001, 9358137.
19. Foresi A, Mastropasqua B, Chetta A, D'Ippolito R, Testi R, Olivieri D, Pelucchi A. Step-down compared to fixed-dose treatment with inhaled fluticasone propionate in asthma. Chest 2005, 127:117-124. 10.1378/chest.127.1.117, 15653971.
20. Fardon T, Haggart K, Lee DK, Lipworth BJ. A proof of concept study to evaluate stepping down the dose of fluticasone in combination with salmeterol and tiotropium in severe persistent asthma. Respir Med 2007, 101:1218-1228. 10.1016/j.rmed.2006.11.001, 17178217.
21. IMS Health - Retail Sales Data
22. Fabbri LM, Nicolini G, Olivieri D, Papi A. Inhaled beclometasone dipropionate/formoterol extra-fine fixed combination in the treatment of asthma: evidence and future perspectives. Expert Opin Pharmacother 2008, 9:479-490. 10.1517/14656566.9.3.479, 18220498.
23. Clearie KL, Jackson CM, Fardon TC, Williamson PA, Vaidyanathan S, Burns P, Lipworth BJ. Supervised step-down of inhaled corticosteroids in the community-an observational study. Respir Med 2011, 05:558-565.